These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
399 related articles for article (PubMed ID: 8968448)
1. Effects of fluvastatin on hyperlipidemia after renal transplantation: influence of steroid therapy. Austen JL; Shifrin FA; Bartucci MR; Knauss TC; Schulak JA; Hricik DE Ann Pharmacother; 1996 Dec; 30(12):1386-9. PubMed ID: 8968448 [TBL] [Abstract][Full Text] [Related]
2. Impact of fluvastatin on hyperlipidemia after renal transplantation. Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777 [TBL] [Abstract][Full Text] [Related]
3. A preliminary report of the safety and efficacy of fluvastatin for hypercholesterolemia in renal transplant patients receiving cyclosporine. Goldberg RB; Roth D Am J Cardiol; 1995 Jul; 76(2):107A-109A. PubMed ID: 7604782 [TBL] [Abstract][Full Text] [Related]
4. Effect of fluvastatin for safely lowering atherogenic lipids in renal transplant patients receiving cyclosporine. Holdaas H; Hartmann A; Stenstrøm J; Dahl KJ; Borge M; Pfister P Am J Cardiol; 1995 Jul; 76(2):102A-106A. PubMed ID: 7604781 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine A. Park JW; Siekmeier R; Lattke P; Merz M; Mix C; Schüler S; Jaross W J Cardiovasc Pharmacol Ther; 2001 Oct; 6(4):351-61. PubMed ID: 11907637 [TBL] [Abstract][Full Text] [Related]
6. Effect of fluvastatin on lipoprotein profiles in treating renal transplant recipients with dyslipoproteinemia. Li PK; Mak TW; Chan TH; Wang A; Lam CW; Lai KN Transplantation; 1995 Oct; 60(7):652-6. PubMed ID: 7570971 [TBL] [Abstract][Full Text] [Related]
7. Combined treatment of hypercholesterolemia of renal transplant allograft recipients with fluvastatin and gemfibrozil. Vergoulas G; Miserlis G; Solonaki F; Imvrios G; Gakis D; Papanikolaou V; Papagiannis A; Visvardis G; Takoudas D; Antoniadis A Transpl Int; 2000; 13 Suppl 1():S64-7. PubMed ID: 11111964 [TBL] [Abstract][Full Text] [Related]
8. Treatment of hypercholesterolemia with fluvastatin in kidney transplant patients. Melchor JL; Gracida C Transplant Proc; 1998 Aug; 30(5):2054. PubMed ID: 9723390 [No Abstract] [Full Text] [Related]
10. Lipid-lowering effects of fluvastatin in renal transplant patients. A clinical observation. Lal SM; Gupta N; Georgiev O; Ross G Int J Artif Organs; 1997 Jan; 20(1):18-21. PubMed ID: 9062827 [TBL] [Abstract][Full Text] [Related]
11. Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin. Skalicka B; Kubanek M; Malek I; Vymetalova Y; Hoskova L; Podzimkova M; Kautzner J J Heart Lung Transplant; 2009 Jun; 28(6):598-604. PubMed ID: 19481021 [TBL] [Abstract][Full Text] [Related]
12. The effect of fluvastatin of hyperlipidemia in renal transplant recipients: a prospective, placebo-controlled study. Türk S; Yildiz A; Tükek T; Akkaya V; Aras U; Türkmen A; Uras AR; Sever MS Int Urol Nephrol; 2001; 32(4):713-6. PubMed ID: 11989571 [TBL] [Abstract][Full Text] [Related]
13. Treatment of combined hyperlipidemia with fluvastatin and gemfibrozil, alone or in combination, does not induce muscle damage. Smit JW; Jansen GH; de Bruin TW; Erkelens DW Am J Cardiol; 1995 Jul; 76(2):126A-128A. PubMed ID: 7604787 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and muscle safety of fluvastatin in cyclosporine-treated cardiac and renal transplant recipients: an exercise provocation test. Schrama YC; Hené RJ; de Jonge N; Joles JA; Van Rijn HJ; Bär DR; Ververs TF; Van Tol A; Koomans HA Transplantation; 1998 Nov; 66(9):1175-81. PubMed ID: 9825814 [TBL] [Abstract][Full Text] [Related]
15. Comparison of treatment with fluvastatin extended-release 80-mg tablets and immediate-release 40-mg capsules in patients with primary hypercholesterolemia. Isaacsohn JL; LaSalle J; Chao G; Gonasun L Clin Ther; 2003 Mar; 25(3):904-18. PubMed ID: 12852707 [TBL] [Abstract][Full Text] [Related]
16. Effects of D-003, a mixture of long-chain aliphatic primary acids, fluvastatin and the combined therapy of D-003 plus fluvastatin on the lipid profile of normocholesterolemic rabbits. Mendoza S; Gamez R; Mas R; Goicochea E Int J Tissue React; 2003; 25(3):81-9. PubMed ID: 14756189 [TBL] [Abstract][Full Text] [Related]
17. Lipid lowering therapy with fluvastatin and pravastatin in patients with HIV infection and antiretroviral therapy: comparison of efficacy and interaction with indinavir. Benesic A; Zilly M; Kluge F; Weissbrich B; Winzer R; Klinker H; Langmann P Infection; 2004 Aug; 32(4):229-33. PubMed ID: 15293079 [TBL] [Abstract][Full Text] [Related]
18. The efficacy and safety of fluvastatin in hypercholesterolemia in renal transplant recipients. Ghods AJ; Milanian I; Arghani H; Ghadiri G Transplant Proc; 1995 Oct; 27(5):2579-80. PubMed ID: 7482835 [No Abstract] [Full Text] [Related]
19. Efficacy and tolerability of fluvastatin extended-release delivery system: a pooled analysis. Ballantyne CM; Pazzucconi F; Pintó X; Reckless JP; Stein E; McKenney J; Bortolini M; Chiang YT Clin Ther; 2001 Feb; 23(2):177-92. PubMed ID: 11293552 [TBL] [Abstract][Full Text] [Related]
20. Fluvastatin in combination with other lipid-lowering agents. Jokubaitis LA Br J Clin Pract Suppl; 1994 Dec; (77):28-32. PubMed ID: 19496270 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]